| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |